Effects of Nutritional Support on Postoperative Delirium

June 17, 2024 updated by: Yonsei University

Effects of Nutritional Support on Postoperative Delirium (POD) in Elderly Non-cardiac Surgical patients_non-inferiority Comparison

This study is a prospective, single-center, randomized controlled trial to compare whether applying nutritional supplementation therapy before and after surgery in elderly patients aged 65 years or older undergoing non-cardiac surgery can reduce the incidence of postoperative delirium.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

314

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Bon-Nyeo koo, MD
  • Phone Number: 82-10-9982-4469
  • Email: koobn@yuhs.ac

Study Locations

      • Seoul, Korea, Republic of, 03722
        • Recruiting
        • Yonsei University Health System, Severance Hospital
        • Contact:
          • bon nyeo koo, MD
          • Phone Number: 82-10-9982-4469
          • Email: koobn@yuhs.ac

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Elderly patients aged 65 and above.
  • Patients undergoing non-cardiac major surgery in thoracic surgery, lung cancer surgery, multi-level spinal surgery in neurosurgery and orthopedics, or liver cancer surgery in hepatobiliary and pancreatic surgery, under general anesthesia with an expected surgery duration of 2 hours or more.
  • Patients scheduled for arterial catheterization.
  • Patients who are able to take oral intake from postoperative day #1.

Exclusion Criteria:

  • Patients with uncontrolled systemic conditions such as diabetes, hypertension, renal disease, liver disease, and other systemic illnesses.
  • Those with visual impairment.
  • Patients with cognitive impairment based on the Mini-Mental State Examination for Dementia Screening criteria.
  • Individuals experiencing difficulty in communication.
  • Those diagnosed with neurological disorders (such as brain hemorrhage, stroke, brain tumor, dementia, Parkinson's disease, cognitive impairment, depression, etc.).
  • Patients diagnosed with alcohol or substance addiction.
  • Patients with cancelled scheduled surgeries.
  • Patients undergoing minor surgeries with expected anesthesia durations of less than 2 hours.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control group
The entire process is carried out according to Severance Hospital surgical protocols.
The entire process is carried out according to Severance Hospital surgical protocols.
Experimental: intervention group
The entire process is carried out according to Severance Hospital surgical protocols. The patients of control group will receive education from the research team about the importance of nutrition and exercise before and after surgery. In addition, the patients of control group will be instructed to take up to 4 doses of the nutritional supplement (Nucare Curact provided by DAESANG Wellife Inc.) per day for approximately 2 weeks before surgery and for about 4 weeks after surgery.
The entire process is carried out according to Severance Hospital surgical protocols. The patients of control group will receive education from the research team about the importance of nutrition and exercise before and after surgery. In addition, the patients of control group will be instructed to take up to 4 doses of the nutritional supplement (Nucare Curact provided by DAESANG Wellife Inc.) per day for approximately 2 weeks before surgery and for about 4 weeks after surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of postoperative delirium
Time Frame: from postoperative day 0 to postoperative day 7

Confusion assessment methods(CAM) will be used for diagnosing delirium At least two times a day during the hospitalization period. Patients diagnosed with delirium using the CAM were evaluated for the duration, symptoms, and type of delirium (e.g., reduced awareness of the environment; poor cognitive skills; behavioral changes; and emotional disturbances).

** Confusion assessment methods(CAM) diagnostic algorism (positive or negative result, positive means delirium)

CAM is considered positive if features 1 and 2 are present, with at least one of features 3 or 4. Below are the four criteria of features :

  1. Acute onset and fluctuating course Determined by collateral history or repeated clinic assessment
  2. Inattention Counting from 20-1 is a simple (if blunt) test for this
  3. Disorganized thinking
  4. Altered levels of consciousness
from postoperative day 0 to postoperative day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
type of delirium
Time Frame: from postoperative day 0 to postoperative day 7
from postoperative day 0 to postoperative day 7
duration of delirium
Time Frame: from postoperative day 0 to postoperative day 7
The Quality of Recovery-40 (QoR-40) : 40~200(better recovery)
from postoperative day 0 to postoperative day 7
K-FRAIL for frailty
Time Frame: from postoperative day 0 to postoperative day 7

The Korean version of the fatigue, resistance, ambulation, illnesses, and loss of weight (K-FRAIL) scale : 0(healthy)~8(frail).

A raw score is standardized. A lower score means cognitive dysfunction.

from postoperative day 0 to postoperative day 7
GDS for depression
Time Frame: from postoperative day 0 to postoperative day 7
Geriatric Depression Scale(GDS) : 0(normal)~ 15(depression). A raw score is standardized. A lower score means cognitive dysfunction.
from postoperative day 0 to postoperative day 7
ADL for independence
Time Frame: from postoperative day 0 to postoperative day 7

Activities of Daily Living(ADL)-Barthel Index : 0(completely dependent )~105( independent).

A raw score is standardized. A lower score means cognitive dysfunction.

from postoperative day 0 to postoperative day 7
SNSB-c for cognitive dysfunction
Time Frame: from postoperative day 0 to postoperative day 7
Seoul Neuropsychological Screening Battery-Core(SNSB-C): total score is 617. A raw score is standardized. A lower score means cognitive dysfunction.
from postoperative day 0 to postoperative day 7
QOR-40 for recovery
Time Frame: from postoperative day 0 to postoperative day 7
The Quality of Recovery-40 (QoR-40) : 40~200(better recovery)
from postoperative day 0 to postoperative day 7
K-MoCA for cognitive dysfunction
Time Frame: from postoperative day 0 to postoperative day 7
Korean-Montreal Cognitive Assessment(K-MoCA) : 0~30, cognitive dysfunction<23.
from postoperative day 0 to postoperative day 7
IADL for independence
Time Frame: from postoperative day 0 to postoperative day 7
Instrumental Activities of Daily Living(IADL)-Lawton-Brody Scale : 0~8(complete independence).
from postoperative day 0 to postoperative day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

May 12, 2028

Study Completion (Estimated)

May 12, 2028

Study Registration Dates

First Submitted

May 20, 2024

First Submitted That Met QC Criteria

June 17, 2024

First Posted (Actual)

June 21, 2024

Study Record Updates

Last Update Posted (Actual)

June 21, 2024

Last Update Submitted That Met QC Criteria

June 17, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on control group

Subscribe